Breakthrough therapy heals spinal cord injuries

FHS
July 27, 2024
5:10 am

In November 2021, Northwestern University researchers introduced an injectable new therapy, which harnessed fast-moving “dancing molecules,” to repair tissues and reverse paralysis after severe spinal cord injuries.

Mixed Results for Tiragolumab/Atezolizumab Combo in PD-L1+ Recurrent Cervical Cancer

SEOUL, South Korea — Combining the novel anti-TIGIT monoclonal antibody tiragolumab with atezolizumab (Tecentriq) to treat PD-L1-positive recurrent cervical cancer didn’t improve overall response rate

November 7, 2023

Pharmaceutical Consulting Companies, Training & Other Services

Share this article Pharmaceutical consulting companies assist pharmaceutical and biotechnology firms throughout product development, from research and innovation to commercialisation. Pharmaceutical consulting covers a broad

March 22, 2024

Bright Green Embarks on Major Partnership With Benuvia Pharmaceuticals Will Supply Pharma Expert With American Made Raw Materials From Its Industry Leading and DEA-Approved SCH I & II Drug Facility | Psychedelic Invest

GRANTS, NEW MEXICO, Aug. 21, 2024 (GLOBE NEWSWIRE) — Bright Green Corporation (Nasdaq: BGXX) (“Bright Green” or the “Company”) today announced that it has signed a letter of intent

August 22, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.